Up to 10 percent of all cancers are inherited. Myriad Genetic Laboratories is a leader in cancer predisposition testing, offering the most accurate, highest-quality clinical tests available to determine predisposition to cancer. Here is an overview of the tests we offer:
A genetic test for hereditary breast and
ovarian cancer
BRACAnalysis® assesses a person's risk of
developing breast or ovarian cancer based on detection of mutations
in the
BRCA1
and BRCA2 genes.
» Read more about
inherited breast and ovarian cancer.
A genetic test for hereditary nonpolyposis
colorectal cancer (HNPCC)
COLARIS® assesses an individual's risk of developing
colorectal, endometrial or other related cancers based on the
detection of mutations in the
MLH1,
MSH2, and MSH6 genes.
» Read more
about inherited colorectal cancer and HNPCC.
A genetic test for adenomatous polyposis
syndromes
COLARIS AP® assesses an individual's risk of
developing colorectal cancer based on detection of mutations in the
APC
and
MYH
genes.
» Read more
about inherited colorectal cancer and adenomatous polyposis
syndromes.
A genetic test for hereditary melanoma
MELARIS® assesses an individual's risk of developing
melanoma and pancreatic cancer, based on the detection of mutations
in the
p16
gene.
» Read more
about inherited melanoma.
